Skip to Content

618 (Aspirin and Extended-Release Dipyridamole 25 mg / 200 mg)

Pill with imprint 618 is Red & White, Capsule-shape and has been identified as Aspirin and Extended-Release Dipyridamole 25 mg / 200 mg. It is supplied by Zydus Pharmaceuticals (USA) Inc..

Aspirin/dipyridamole is used in the treatment of ischemic stroke, prophylaxis and belongs to the drug class platelet aggregation inhibitors. There is positive evidence of human fetal risk during pregnancy. Aspirin/dipyridamole 25 mg / 200 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 618

Aspirin and Extended-Release Dipyridamole

Imprint
618
Strength
25 mg / 200 mg
Color
Red & White
Size
24.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Platelet aggregation inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Zydus Pharmaceuticals (USA) Inc.
Manufacturer
Cadila Healthcare Limited
National Drug Code (NDC)
68382-0618
Inactive Ingredients
alcohol, ammonia, butyl alcohol, microcrystalline cellulose, D&C Yellow No. 10, FD&C Red No. 40, ferrosoferric oxide, gelatin, hypromellose phthalate (31% phthalate, 40 cst), hypromelloses, isopropyl alcohol, lactose monohydrate, methacrylic acid - methyl methacrylate copolymer (1:2), polyethylene glycol, potassium hydroxide, povidone, propylene glycol, shellac, sodium lauryl sulfate, corn starch, stearic acid, magnesium silicate, tartaric acid, titanium dioxide, triethyl citrate, water

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "618"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.